|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C12N 15/11 | (2006.01) |
| C12N 15/113 | (2006.01) | ||
| A61K 31/713 | (2006.01) |
| (11) | Number of the document | 2937418 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15151452.8 |
| Date of filing the European patent application | 2009-10-20 | |
| (97) | Date of publication of the European application | 2015-10-28 |
| (45) | Date of publication and mention of the grant of the patent | 2017-10-18 |
| (46) | Date of publication of the claims translation | 2018-02-12 |
| (30) | Number | Date | Country code |
| 106956 P | 2008-10-20 | US | |
| 115738 P | 2008-11-18 | US | |
| 156670 P | 2009-03-02 | US | |
| 185545 P | 2009-06-09 | US | |
| 242783 P | 2009-09-15 | US | |
| 244794 P | 2009-09-22 | US |
| (72) |
Sah, Dinah Wen-yee, US
Hinkle, Gregory, US
Alvarez, Rene, US
Milstein, Stuart, US
Chen, Qingmin, US
|
| (73) |
Alnylam Pharmaceuticals, Inc.,
300 Third Street, 3rd Floor, Cambridge, MA 02142,
US
|
| (74) |
Liudmila GERASIMOVIČ,
IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius,
LT
|
| (54) | Kompozicijos ir būdas transtiretino raiškos slopinimui |
| Compositions and methods for inhibiting expression of transthyretin |
| Payment date | Validity (years) | Amount | |
| 2025-09-30 | 17 | 347.00 EUR |
| 2026-10-20 |